[ad_1]
Almost a million people have already received a coronavirus vaccine. It occurs in China, where a pharmaceutical giant has reached out to a social media post that it has developed and tested the vaccine in the country. So far there have been no serious reactions in the volunteers.
China, coronavirus vaccine administered to almost a million people
While in Italy the virologist Andrea Crisanti warns against “early” vaccines, that is, those that would arrive in January or earlier, in China the treatment of the coronavirus is being distributed. In fact, the administration of the candidate vaccine in the Asian country is not experimental. emergency.
In a post on the social network WeChat, the Chinese group Sinopharm, quoting the president Liu JingzhenHe said: “So far our advancements, both in research and development, clinical trials, manufacturing and emergency use, are leading in all respects globally. In terms of emergency use, we have now used it in almost a million people and have received no reports of serious adverse reactions, only some have mild symptoms. “
Sinopharm, Chinese vaccine “superior” to the competition
According to the company, in short, the Chinese vaccine would be “in all respects” superior to the competition also from top-of-the-line candidates from Pfizer and Moderna, where test results have been released in recent days.
However, unlike its American rivals, Sinopharm did not disclose data on effectiveness nor what are the side effects, however minor, experienced by the candidates.
Liu said the vaccine was administered to Chinese construction workers, diplomats and students who traveled to more than 150 countries around the world, and none of them were infected with the coronavirus.
Sinopharm has two vaccine candidates. It did not reveal which of the two the data refers to.
Back in Italy, the virologist Crisanti unleashed a storm by claiming that the doses arriving in Italy in January would not be safe, because development times are often much longer.
Other candidate vaccines are in the process of being mass distributed in the United States and Russia as well.
